Alt5 Sigma Corporation has appointed Dr. Adel ElMessiry as an independent director to its board. Dr. ElMessiry brings experience in technology leadership, fintech, blockchain systems, and governance. He currently serves as President and Chief Technology Officer of AlphaFin and is involved in several other technology ventures and nonprofit organizations.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alt5 Sigma Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-005089), on February 04, 2026, and is solely responsible for the information contained therein.
Comments